Guanfacine to Treat Borderline Personality Disorder

Status unconfirmed · Not applicable

Conditions studied: Borderline Personality Disorder

In brief

This study is designed to investigate whether guanfacine (Tenex) is an effective treatment for borderline personality disorder (BPD), an illness often characterized by unstable mood and impulsive aggression. Guanfacine stimulates activity in the front portion of the brain, a region associated with attention and the control of behavior. We believe that guanfacine may improve symptoms of BPD by improving attention and aiding regulation of behavior.

Key facts

Study ID

NCT00358969

Run by

Icahn School of Medicine at Mount Sinai

Starts

2006-07-01

Last updated by the study team

2006-08-01

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mount Sinai Hospital - Mood & Personality Research Group — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.